Digital Pathology Market

The report "Digital Pathology Market by Product (Brightfield Scanner, Enterprise Software, Storage System), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), Indication (Onco, Hemo), End User (Pharma & Biotech, Hospital) Al- Global Forecast to 2031" is projected to reach USD 2.86 billion by 2031 from USD 1.58 billion in 2026, at a CAGR of 12.5% from 2026 to 2031.

Browse 310 market data Tables and 50 Figures spread through 283 Pages and in-depth TOC on "Digital Pathology Market by Product (Brightfield Scanner, Enterprise Software, Storage System), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), Indication (Onco, Hemo), End User (Pharma & Biotech, Hospital) Al- Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/digital-pathology-market-844.html

The digital pathology market is driven by several major factors. One of the biggest drivers is the increasing shift from traditional microscope-based diagnosis to fully digital workflows. Hospitals and diagnostic laboratories are adopting whole slide imaging systems, which allow pathologists to view, store, and share tissue samples in digital form. Growing use of AI and machine learning in digital pathology systems. These technologies help pathologists by highlighting abnormal tissue patterns, improving cancer detection accuracy, and reducing manual workload. AI-based tools are also being used in research and drug development to identify biomarkers and analyze large sets of tissue images faster than traditional methods. This is making digital pathology more valuable not only for diagnosis but also for research and pharmaceutical companies. The increasing adoption of cloud-based platforms is also supporting market growth. Cloud systems allow hospitals, labs, and research centers to store and access large pathology image files from anywhere. For instance, in February ‘24, Roche collaborated with PathAI to develop an AI-enabled digital pathology algorithm for companion diagnostics. This collaboration will enable Roche to accelerate its efforts to meet the growing demand from biopharma companies focused on developing AI-enabled CDx.

The veterinary pathology segment will show the fastest growth in the digital pathology market.

By type, the veterinary pathology segment is expected to register the fastest growth in the digital pathology market. This strong growth is mainly due to the increasing use of digital pathology technology for applications in veterinary diagnostics, preclinical research, and toxicologic pathology. Increasing costs associated with the health care of companion animals, along with growing demand for advanced diagnostics, are boosting the use of technology in veterinary laboratories. Further, growing R&D activities in the pharmaceutical and biotech sectors, along with the increasing involvement of CROs conducting experiments on animals, are contributing positively toward the growth of the market.

The oncology segment held the largest share of the digital pathology market in 2025.

Based on therapeutic segment, the digital pathology market is divided into digital oncology, hematology, gastroenterology, infectious diseases, neurology, and other therapeutic areas. In 2025, the oncology segment is expected to hold the largest share of the digital pathology market. The increasing use of precision medicine and personalized cancer therapies has added to the already burgeoning demand for digital pathology technology in oncology. Digital pathology solutions are widely used in healthcare to support companion diagnostics, biomarker discovery, clinical trials, and treatment response monitoring. Moreover, with the increasing use of computational pathology solutions, cancer detection and quantification have become faster and more consistent. In March 2025, an article published in Black Book Research reported that more than 70% of biotechnology and life sciences companies now use digital pathology for drug development and biomarker analysis, underscoring its growing importance beyond traditional disease diagnosis.

The Asia Pacific is expected to register the highest growth during the forecast period.

The digital pathology market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is expected to register the highest growth during the forecast period. Factors driving growth in this region include rising disposable incomes and rapid improvements in healthcare access and infrastructure. With nearly two-thirds of the global population living in this region, the need for advanced diagnostic solutions such as digital pathology is growing rapidly. Governments across the region are also actively supporting healthcare modernization. For example, China’s Healthy China 2030 plan is focused on expanding healthcare services and improving digital health infrastructure. Similarly, India has seen strong growth in healthcare spending over the past few years, driven by both public and private investment, as well as improvements in medical technology and diagnostic equipment. In addition, healthcare investment in the Asia-Pacific region is among the fastest-growing global trends, particularly in Southeast Asia, where countries are investing heavily in healthcare infrastructure and digital transformation.

Don’t miss out on business opportunities in digital pathology market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com